Benzinga's Top Upgrades, Downgrades For September 7, 2018

Top Upgrades

• Bank of America upgraded AK Steel Holding Corporation AKS from Underperform to Buy. AK Steel shares rose 2.36 percent to $4.33 in pre-market trading.
• Argus upgraded Southwest Airlines Co LUV from Hold to Buy. Southwest shares rose 0.77 percent to $61.50 in pre-market trading.
• Jefferies upgraded Vale SA (ADR) VALE from Hold to Buy. Vale shares rose 2.08 percent to $13.26 in pre-market trading.
• SunTrust Robinson Humphrey upgraded Centennial Resource Development Inc CDEV from Hold to Buy. Centennial Resource Development shares fell 0.99 percent to close at $18.94 on Thusrday.

Top Downgrades

• Macquarie downgraded Wells Fargo & Co WFC from Outperform to Neutral. Wells Fargo shares fell 0.59 percent to $57.59 in pre-market trading.
• Deutsche Bank downgraded T. Rowe Price Group Inc TROW from Buy to Hold. T. Rowe Price shares fell 1.2 percent to $111.90 in pre-market trading.
• SunTrust Robinson Humphrey downgraded Cimarex Energy Co XEC from Buy to Hold. Cimarex Energy shares fell 0.77 percent to close at $85.47 on Thursday.
• BMO Capital downgraded Dover Corp DOV from Outperform to Market Perform. Dover shares fell 0.39 percent to $86.00 in pre-market trading.
• Raymond James downgraded Core-Mark Holding Company, Inc. CORE from Strong Buy to Outperform. Core-Mark shares rose 1.01 percent to close at $36.96 on Thursday.

Top Initiations

• B. Riley FBR initiated coverage on Audentes Therapeutics Inc BOLD with a Sell rating. The price target for Audentes Therapeutics is set to $20. Audentes Therapeutics shares closed at $37.09 on Thursday.
• Cantor Fitzgerald initiated coverage on Tabula Rasa HealthCare Inc TRHC with an Overweight rating. The price target for Tabula Rasa HealthCare is set to $99. Tabula Rasa HealthCare shares closed at $83.95 on Thursday.
• Mizuho initiated Unity Biotechnology Inc UBX with a Buy rating. The price target for Unity Biotechnology is set to $33. Unity Biotechnology shares closed at $18.02 on Thursday.
• Analysts at B. Riley FBR initiated coverage on Homology Medicines Inc FIXX with a Neutral rating. The price target for Homology Medicines is set to $18.50. Homology Medicines shares closed at $15.96 on Thursday.
• Cantor Fitzgerald initiated coverage on Menlo Therapeutics Inc MNLO with an Overweight rating. The price target for Menlo Therapeutics is set to $25. Menlo Therapeutics shares closed at $7.63 on Thursday.
• Analysts at B. Riley FBR initiated coverage on Zogenix, Inc. ZGNX with a Buy rating. The price target for Zogenix is set to $116. Zogenix shares closed at $45.65 on Thursday.
• Oppenheimer initiated coverage on Caterpillar CAT with a Neutral rating. Caterpillar shares closed at $141.57 on Thursday.
• Raymond James initiated coverage on Trupanion Inc TRUP with an Outperform rating. The price target for Trupanion is set to $46. Trupanion shares closed at $37.37 on Thursday.